Liver Cancer Institute, Zhongshan Hospital, and Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai, 200032, China.
Liver Cancer Institute, Zhongshan Hospital, and Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai, 200032, China; Institute of Biomedical Sciences, Fudan University, Shanghai, 200032, China.
Cancer Lett. 2018 Jan 1;412:108-117. doi: 10.1016/j.canlet.2017.10.012. Epub 2017 Oct 20.
MiRNA-30a (miR-30a) was previously reported as one of metastatic hepatocellular carcinoma (HCC)-related microRNAs. However, the function of miR-30a on enhancing our biological understanding of HCC metastasis is not clear. This study demonstrated that miR-30a was significantly down-regulated in HCC tissues and cell lines, and was associated with vascular invasion, metastasis potential and recurrent disease in HCC. Functional studies confirmed that miR-30a could inhibit the metastasis of HCC in a well-established nude mouse model of lung metastasis. Moreover, miR-30a was proved to prevent anoikis inhibition of HCC cells in vivo and in vitro. Mechanically, autophagy related protein Beclin 1 and Atg5 were direct downstream targets of miR-30a, and mediated autophagy activity influence of miR-30a in HCC. Taken together, downregulated miR-30a in metastatic HCC mediates Beclin 1 and Atg5-dependent autophagy, which confers anoikis resistance in HCC cells. The molecular basis of autophagy action during this process partly contributes to the HCC metastasis, suggesting that targeting autophagy via miR-30a may have therapeutic implications for the prevention of HCC recurrence/metastasis.
miRNA-30a(miR-30a)先前被报道为与转移性肝细胞癌(HCC)相关的 microRNA 之一。然而,miR-30a 增强我们对 HCC 转移生物学理解的功能尚不清楚。本研究表明,miR-30a 在 HCC 组织和细胞系中显著下调,与 HCC 中的血管侵犯、转移潜能和复发病有关。功能研究证实,miR-30a 可抑制 HCC 在建立良好的裸鼠肺转移模型中的转移。此外,miR-30a 被证明可防止 HCC 细胞在体内和体外的失巢凋亡抑制。从机制上讲,自噬相关蛋白 Beclin 1 和 Atg5 是 miR-30a 的直接下游靶标,并且介导 miR-30a 在 HCC 中的自噬活性影响。总之,转移性 HCC 中下调的 miR-30a 介导了 Beclin 1 和 Atg5 依赖性自噬,赋予了 HCC 细胞对失巢凋亡的抗性。在此过程中自噬作用的分子基础部分有助于 HCC 转移,提示通过 miR-30a 靶向自噬可能对预防 HCC 复发/转移具有治疗意义。